Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis

Newacheck, 1994, Prevalence and impact of multiple childhood chronic illnesses, J Pediatr, 124, 40, 10.1016/S0022-3476(94)70252-7 2001 Meltzer, 2002, Clinical evidence for antileukotriene therapy in the management of allergic rhinitis, Ann Allergy Asthma Immunol, 88, 23, 10.1016/S1081-1206(10)62025-X Adelsberg, 2003, Montelukast improves symptoms of allergic rhinitis over a 4-week treatment period, Allergy, 58, 1268, 10.1046/j.1398-9995.2003.00261.x Philip, 2002, Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performing in the spring, Clin Exp Allergy, 32, 1020, 10.1046/j.1365-2222.2002.01422.x Philip, 2004, The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis, Curr Med Res Opin, 20, 1549, 10.1185/030079904X3348 Adelsberg, 2003, Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 90, 214, 10.1016/S1081-1206(10)62144-8 Meltzer, 2000, Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial, J Allergy Clin Immunol, 105, 917, 10.1067/mai.2000.106040 Kurowski, 2004, Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation, Allergy, 59, 280, 10.1046/j.1398-9995.2003.00416.x Barnes, 1995, Nitric oxide and asthmatic inflammation, Immunol Today, 16, 128, 10.1016/0167-5699(95)80128-6 Kharitonov, 1996, Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract, Am J Respir Crit Care Med, 153, 1773, 10.1164/ajrccm.153.6.8665033 Gratziou, 2001, Exhaled nitric oxide in seasonal allergic rhinitis: influence of pollen season and therapy, Clin Exp Allergy, 31, 409, 10.1046/j.1365-2222.2001.01001.x Wilson, 2002, A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis, Clin Exp Allergy, 32, 126, 10.1046/j.0022-0477.2001.01252.x Gratziou, 1999, Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis, Eur Respir J, 14, 897, 10.1034/j.1399-3003.1999.14d28.x Sandrini, 2003, Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis, J Allergy Clin Immunol, 111, 313, 10.1067/mai.2003.64 Baraldi, 2002, ERS/ATS statement. Measurement of exhaled nitric oxide in children, 2001, Eur Respir J, 20, 223, 10.1183/09031936.02.00293102 Keskin, 2006, Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?, Pediatr Allergy Immunol, 17, 259, 10.1111/j.1399-3038.2006.00397.x Linden, 1999, Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis, Allergy, 54, 212, 10.1034/j.1398-9995.1999.00756.x Miadonna, 1999, Nasal response to a single antigen challenge in patients with allergic rhinitis-inflammatory cell recruitment persists up to 48 hours, Clin Exp Allergy, 29, 941, 10.1046/j.1365-2222.1999.00609.x Winther, 1999, Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis, Allergy, 54, 436, 10.1034/j.1398-9995.1999.00910.x Frick, 1988, Hypodense eosinophils in allergic rhinitis, J Allergy Clin Immunol, 82, 119, 10.1016/0091-6749(88)90061-9 Bhandari, 1976, Relative value of peripheral blood, secretion and tissue eosinophilia in the diagnosis of different patterns of allergic rhinitis, Ann Allergy, 37, 280 Knorr, 1998, Montelukast for chronic asthma in 6 to 14 year old children: a randomized, double-blind trial, JAMA, 279, 1181, 10.1001/jama.279.15.1181 Reis, 1998, Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial, Arch Intern Med, 158, 1213, 10.1001/archinte.158.11.1213 Fabbri, 1998, Assessment of airway inflammation: an overview, Eur Respir J, 26, 6S Lopuhaa, 2003, Similar levels of nitric oxide in exhaled air in non-asthmatic rhinitis and asthma after bronchial allergen challenge, Allergy, 58, 300, 10.1034/j.1398-9995.2003.00075.x Jouaville, 2003, Interrelationship among asthma, atopy, rhinitis and exhaled nitric oxide in a population-based sample of children, Clin Exp Allergy, 33, 1506, 10.1046/j.1365-2222.2003.01800.x Martin, 1996, Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis, J Allergy Clin Immunol, 97, 768, 10.1016/S0091-6749(96)80154-0 Henriksen, 1999, Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness, Eur Respir J, 13, 301, 10.1034/j.1399-3003.1999.13b14.x Golden, 2005, The role of leukotrienes in allergic rhinitis, Ann Allergy Asthma Immunol, 94, 609, 10.1016/S1081-1206(10)61317-8 Prieto, 2002, Concentrations of exhaled nitric oxide in asthmatics and subjects with allergic rhinitis sensitized to the same pollen allergen, Clin Exp Allergy, 32, 1728, 10.1046/j.1365-2222.2002.01546.x Prieto, 2002, Modifications of airway responsiveness to adenosine 5'-monophosphate and exhaled nitric oxide concentrations after the pollen season in subjects with pollen-induced rhinitis, Chest, 122, 940, 10.1378/chest.122.3.940 Prieto, 2002, Exhaled nitric oxide and bronchial responsiveness to adenosine 5'-monophosphate in subjects with allergic rhinitis, Chest, 121, 1853, 10.1378/chest.121.6.1853 Ching, 2005, Relationship to exhaled nitric oxide and atopy in Asian young adults, Respirology, 10, 40, 10.1111/j.1440-1843.2005.00628.x Wilson, 2000, Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma, Am J Respir Crit Care Med, 162, 1297, 10.1164/ajrccm.162.4.9912046 Wilson, 2001, A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma, Clin Exp Allergy, 31, 616, 10.1046/j.1365-2222.2001.01088.x Cardinale, 2005, Exhaled nitric oxide, total serum IgE and allergic sensitization in childhood asthma and allergic rhinitis, Pediatr Allergy Immunol, 16, 236, 10.1111/j.1399-3038.2005.00265.x Jatakan, 1998, Correlation between exhaled nitric oxide sputum eosinophils, and methacholine responsiveness in patients with mild asthma, Thorax, 53, 91, 10.1136/thx.53.2.91 Berlyne, 2000, A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation, J Allergy Clin Immunol, 106, 638, 10.1067/mai.2000.109622 Jatakanon, 1999, Neutrophilic inflammation in severe persistent asthma, Am J Respir Crit Care Med, 160, 1532, 10.1164/ajrccm.160.5.9806170 Lim, 2000, Relationship between exhaled nitric oxide and mucosal eosictphilic inflammation in mild to moderately severe asthma, Thorax, 55, 184, 10.1136/thorax.55.3.184 Turktas, 2003, Correlation of exhaled nitric oxide levels and airway inflammation markers in stable asthmatic patients, J Asthma, 40, 425, 10.1081/JAS-120018715